The Walden Group Releases 2022 Year-End Strategic Healthcare M&A Report


The Walden Group is pleased to provide access to its Q4 2022 Strategic Healthcare M&A Report, which includes:  

  •     Recent Divestitures and Spin-Offs
  •     Diagnostic and Medical Device Deals with Valuations over $100m
  •     Noteworthy M&A Deals By Sector
  •     Top Deals > $100m in Transaction Value Announced or Closed in 2022
  •     Performance of Leading Healthcare Companies
  •     Analysis of More Than 45 Q4 M&A Transactions

Click here to download the Report.